Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 294 participants.
Also called NCT03772041
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 294 participants
- Registry
-
NCT03772041
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT03772041. Randomized; double masking; primary purpose treatment. Start 2019-01-16 (actual); primary completion 2020-07-21 (actual). Results posted on 2021-08-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
- Condition
- Congestive Heart Failure
- Intervention (Drug)
- OPC-61815
- Intervention (Drug)
- Tolvaptan Tab 15 MG
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct03772041- Content hash
dc0139bd17c06b1cee1de4ba8870dd0ca6790ef6269a03a139c2297b800693b4